Key Insights

Highlights

Success Rate

79% trial completion

Published Results

16 trials with published results (22%)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 49/100

Termination Rate

9.7%

7 terminated out of 72 trials

Success Rate

79.4%

-7.2% vs benchmark

Late-Stage Pipeline

8%

6 trials in Phase 3/4

Results Transparency

59%

16 of 27 completed with results

Key Signals

16 with results79% success

Data Visualizations

Phase Distribution

57Total
Not Applicable (12)
Early P 1 (1)
P 1 (21)
P 2 (17)
P 3 (4)
P 4 (2)

Trial Status

Completed27
Recruiting18
Terminated7
Active Not Recruiting6
Not Yet Recruiting6
Unknown5

Trial Success Rate

79.4%

Benchmark: 86.6%

Based on 27 completed trials

Clinical Trials (72)

Showing 20 of 20 trials
NCT00840853Phase 1Active Not RecruitingPrimary

Multi-virus CTLs Expressing CD19 Chimeric Receptors, CD19 Positive Malignancies Post SCT, MULTIPRAT

NCT07246213Recruiting

CAYA Cancer Retrospective Cohort Study

NCT07632014Recruiting

CAYA Cancer Prospective Cohort Study

NCT03849651Phase 2Active Not RecruitingPrimary

TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies

NCT05884333Phase 2Recruiting

Cord Blood Transplant in Adults With Blood Cancers

NCT07586618Phase 1Recruiting

First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.

NCT07483476RecruitingPrimary

Study of Cell-free DNA in Children and Adolescents With Acute Lymphoblastic Leukemia

NCT03740334Phase 1Active Not RecruitingPrimary

Ribociclib in Combination With Everolimus and Dexamethasone in Relapsed ALL

NCT07227584Phase 2Recruiting

ALL Backbone in AYAs

NCT07191119Not ApplicableRecruiting

Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic Leukemia

NCT07742891Not ApplicableNot Yet RecruitingPrimary

ReSeT in ALL 2: A Randomized, Controlled Pilot Trial Testing an Optimized, Multi-component Mobile Health Intervention to Reduce Sedentary Time in Early Adolescents and Young Adults (eAYAs) With ALL During Maintenance Therapy

NCT06764238Phase 2RecruitingPrimary

Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL Protocol

NCT06182163Not ApplicableCompletedPrimary

Reduce Sedentary Time in Acute Lymphoblastic Leukemia

NCT01351545Recruiting

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

NCT05366569Recruiting

Bio-CAR-T BS Study

NCT07529223Not ApplicableNot Yet RecruitingPrimary

Role of T Lymphocytes in Hypersensitivity Reactions to Asparaginase in Patients Treated for Acute Lymphoblastic Leukemia.

NCT03590171Phase 2RecruitingPrimary

International Study for Treatment of High Risk Childhood Relapsed ALL 2010

NCT01758042Not ApplicableCompleted

Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders

NCT02730299Phase 3Completed

Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS

NCT06705530Phase 1Completed

A Study to Evaluate the Tolerability, Safety, and Efficacy of an Anti-CD19 CAR-T Product in Patients With B-cell Lymphoproliferative Disorders

Scroll to load more

Research Network

Activity Timeline